Healthcare
Systems engineering is transforming healthcare, from enhancing disease understanding to enabling advanced therapies and personalized treatments. Sargent Centre researchers are leading this change, studying diseases like cancer and diabetes, and exploring therapies from peptides and mRNA vaccines to small molecule drugs. They collaborate with medical experts and manufacturers to maximize their research impact.
Highlighted Case study:
Optimisation of Vaccine Manufacturing and Supply Chain
A team from the Sargent Centre, led by Professor Shah with Professor Kontoravdi, Dr. Papathanasiou and Dr. Kis, has played an important role in the Future Vaccine Manufacturing Research (FVMR) Hub coordinated by Imperial College London.
Flagship Project
Peptide drugs have already revolutionised the treatment of type 2 diabetes and are set to transform many more treatments. New approaches to process development are needed to overcome the challenge of manufacturing these medicines in sufficient quantities.
More about healthcare
Events
Find the latest courses and seminars on offer at the Centre.
Case studies
Our case studies cover a wide range of topics. For further information please click below.
Publications
Our latest publications.
Healthcare Lead
Sargent Centre Director and Healthcare Lead
Chemical Engineering – Imperial
She is the Director of the Sargent Centre for Process Systems Engineering and Editor-in-Chief of the RSC-IChemE journal MSDE.
Key people
Sargent Centre
The Sargent Centre for Process Systems Engineering is a multi-institutional research centre of world-class departments at Imperial College London and University College London
More about the Sargent Centre
Events
Find the latest courses and seminars on offer at the Centre
Partnerships
The Industrial Consortium provides an exclusive gateway to reap the benefits of our extensive research portfolio and to engage with a vibrant community of over 250 dedicated researchers.
News
Find out more on the latest news.
Work with us and become a member
The Industrial Consortium provides an exclusive gateway to reap the benefits of our extensive research portfolio and to engage with a vibrant community of over 250 dedicated researchers.
